Tag: Oncolytics Biotech

April 30, 2019

BBHIC 2019, Day 1: Notes from the Floor

For INN, day one was full of company presentations, interviews and a panel discussion on commercial-stage healthcare companies.
April 9, 2019

5 Top Biotech Stocks on the TSX Q1 2019

Which biotech stocks on the TSX have performed the best in Q1 2019? Here's a look at those five top...
October 22, 2018

8 Top Gains and Losses at 2018’s ESMO Event

Big Pharma players and smaller oncology-focused companies alike were among the presenters at the annual meeting, which runs from October...
September 28, 2018

Oncolytics Biotech Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln Park Capital

Oncolytics Biotech (NASDAQ:ONCY,TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced the execution of a...
September 11, 2018

New Collaboration for Oncolytics Biotech and SOLTI

On Monday, Oncolytics Biotech announced the details of a new collaboration for its Phase 3 clinical trial.
September 10, 2018

Oncolytics Biotech Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cancer with Pelareorep

Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced a clinical...
July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...